Get the tools used by (smart)2 investors.
Sign In
WatchlistsIdeasScreenerData ExplorerChartsSaved Work

EV / EBITDA for AstraZeneca PLC

Join now and get access to the full platform

Search for company or ETF

 

  0 results available. Select is focused ,type to refine list, press Down to open the menu,

AZN: AstraZeneca PLC

AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines. The company offers Imjudo, Datroway, Iressa, Tagrisso...

- GBP
Price
– GBP
Fair Value
–
Upside
- - -
52-week range
Create ChartCreate ModelAdd To Watchlist

Analysis

Fiscal Years
Trailing Twelve Months
Fiscal Halfs
Fiscal Quarters
Daily
Hide this widget

The following section summarizes insights on AstraZeneca PLC's EV / EBITDA:

Dec 2016Dec 2018Dec 2020Dec 2022Dec 202420.0x30.0x40.0x
Performance Summary
  • AstraZeneca's latest twelve months ev / ebitda is 13.8x
  • AstraZeneca's ev / ebitda for fiscal years ending December 2020 to 2024 averaged 20.0x.
  • AstraZeneca's operated at median ev / ebitda of 18.9x from fiscal years ending December 2020 to 2024.
  • Looking back at the last 5 years, AstraZeneca's ev / ebitda peaked in December 2021 at 30.6x.
  • AstraZeneca's ev / ebitda hit its 5-year low in December 2024 of 13.8x.
  • AstraZeneca's ev / ebitda decreased in 2020 (18.9x, -50.8%), 2022 (22.9x, -25.2%), 2023 (14.0x, -38.6%), and 2024 (13.8x, -1.4%) and increased in 2021 (30.6x, +61.3%).

How does AstraZeneca's EV / EBITDA benchmark against competitors?

Hide this widget

We've identified the following companies as similar to AstraZeneca PLC because they operate in a related industry or sector. We also considered size, growth, and various financial metrics to narrow down the list to the ones listed below.

AstraZeneca EV / EBITDA Benchmarks
NameTickerEV / EBITDA
HealthcareSECTOR:HLTH.GB-0.9x
Viatris Inc.LSE:0A5V5.1x
Bristol-Myers Squibb CompanyLSE:0R1F7.2x
Teva Pharmaceutical Industries LimitedLSE:0LER7.3x
Pfizer Inc.LSE:0Q1N7.6x
Merck & Co IncLSE:0QAH8.1x
GSK plcLSE:GSK8.2x
Novartis AGLSE:0QLR11.3x
Dr Reddy’s Laboratories LtdBSE:50012411.9x
Johnson & JohnsonLSE:0R3412.9x
AstraZeneca PLCLSE:AZN13.8x
HALEON PLCLSE:HLN15.6x

Metric Usage: EV / EBITDA

Hide this widget
ev_to_ebitda_ltm
Slug
number
Datatype
x.x
Format
LTM
Default Period
FY, LTM
Periods Supported
Free
Plan

Data is returned as a standard number. Suggested format is a multiple (e.g 7.0x).

To view the full list of supported financial metrics please see Complete Metrics Listing.

Similar Metrics

Search for metric or datapoint

EV / EBITDA

Measures the dollars in Enterprise Value for each dollar of EBITDA over the last twelve months.

Definition of EV / EBITDA

Sector Benchmark Analysis

Sector
Industry Group
Industry
Hide this widget
-66.4x-31.4x3.6x63.7x100300500

The chart above depicts the distribution of ev / ebitda for companies operating in the Healthcare sector in the Developed economic region. Over 2,185 companies were considered in this analysis, and 2,102 had meaningful values. The average ev / ebitda of companies in the sector is 1.3x with a standard deviation of 14.0x.

AstraZeneca PLC's EV / EBITDA of 13.8x ranks in the 87.1% percentile for the sector. The following table provides additional summary stats:

EV / EBITDA In The Healthcare Sector
Economic Risk RegionDeveloped
Total Constituents2,190
Included Constituents2,102
Min-65.4x
Max62.7x
Median-0.3x
Mean1.3x
Standard Deviation14.0x

You can find companies with similar ev / ebitda using this stock screener.

All rights reserved. Terms Of Use